Descriptive study of severe infections treated with phage therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PHAGEinLYON Clinic cohort study is an observational study that examines patients with severe infections who have been treated with bacteriophage therapy at the Hospices Civils de Lyon from 2015 to 2033. This study includes both retrospective and prospective data collection, aiming to describe the characteristics and outcomes of these severe infections. A total of 250 patients will be enrolled to provide a comprehensive overview of the effectiveness and application of phage therapy in this context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
* PHAGEinLYON Clinic cohort study information notice provided to the patient

Exclusion Criteria:

* Opposition of trial participant

Where it's running

• Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon
  Lyon, France Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Infectious complications in blood cancer patients treated with bispecific antibodies

  This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.

  Recruiting at 2 sites Infanta Leonor University Hospital · Madrid, Madrid and 1 other locations · NCT07609576

• N-acetylcysteine for severe infection with liver dysfunction in adults

  In adults with acute infection or sepsis and liver dysfunction, this study tests whether giving N-acetylcysteine in a four-hour infusion improves days alive and out of the hospital in the first 14 days.

  Recruiting Phase 4 University Hospital Bispebjerg and Frederiksberg · Copenhagen · NCT07273071

• Continuous infusion vs intermittent dosing of ceftazidime/avibactam in critically ill patients

  This study tests whether giving ceftazidime/avibactam as a continuous infusion works better than standard intermittent dosing for seriously ill ICU patients with certain resistant infections.

  Recruiting Phase 4 Clinical Hospital Centre Zagreb · Zagreb · NCT06811727

• Monitoring severe bacterial infections in hospitalized children

  This study looks at how common and serious bacterial infections are in children in intensive care to help improve how these infections are treated and prevented.

  Recruiting Association Clinique Thérapeutique Infantile du val de Marne · Créteil · NCT06260345

• Individualized vancomycin dosing for severe infections

  This study tests if giving personalized doses of vancomycin can help people with severe infections do better than the standard dosing method.

  Recruiting Phase 4 Central South University · Changsha, Hunan · NCT06161870

• Investigating severe infections in pediatric intensive care units in China

  This study is trying to gather important information about severe infections in children in intensive care units across China to see how common they are and how well different treatments work.

  Recruiting Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT04923828

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.